{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/abbvie-announces-european-commission-approval-of-aquipta-atogepant-for-the-acute-treatment-of-migraine-in-adults-302787637.html", "message": "News view counter 772757 successfully enlarged"}